Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Del(6)(q22) and BCL6 Rearrangements in Primary CNS Lymphoma Are Indicators of an Aggressive Clinical Course
2008
Inhibition of Mammalian Target of Rapamycin Reverses Alveolar Epithelial Neoplasia Induced by Oncogenic K-ras
2005
Change of Serum Antithyroglobulin Antibody Levels Is Useful for Prediction of Clinical Recurrence in Thyroglobulin-Negative Patients with Differentiated Thyroid Carcinoma
2008
The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications
2011
The Epidemic of Non–Hodgkin Lymphoma in the United States: Disentangling the Effect of HIV, 1992–2009
2013
Final Version of 2009 AJCC Melanoma Staging and Classification
2009 Standout
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
BRAFV600E Mutation and Outcome of Patients with Papillary Thyroid Carcinoma: A 15-Year Median Follow-Up Study
2008
Conservative management of well-differentiated thyroid cancer.
2010
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Implications of Thyroglobulin Antibody Positivity in Patients with Differentiated Thyroid Cancer: A Clinical Position Statement
2013
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
PIK3CA Mutations and Copy Number Gains in Human Lung Cancers
2008
Uncommon Mutation, but Common Amplifications, of thePIK3CAGene in Thyroid Tumors
2005
Response and determinants of cancer cell susceptibility to PI3K inhibitors: Combined targeting of PI3K and Mek1 as an effective anticancer strategy
2008
Molecular Classification of Thyroid Nodules Using High-Dimensionality Genomic Data
2010
Characterization of Micrometastatic Disease in Melanoma Sentinel Lymph Nodes by Enhanced Pathology
2005
Interleukin-10 Inhibition of HLA-DR Expression in Human Herpes Stromal Keratitis
1994
Lymphocytic Thyroiditis on Histology Correlates with Serum Thyroglobulin Autoantibodies in Patients with Papillary Thyroid Carcinoma: Impact on Detection of Serum Thyroglobulin
2012
Multimodality therapeutic outcomes In anaplastic thyroid carcinoma: Improved survival in subgroups of patients with localized primary tumors
2011
The management of advanced thyroid cancer
2004
Novel Strategies for the Early Detection and Prevention of Lung Cancer
2005
Retinoic acid receptors: From molecular mechanisms to cancer therapy
2014
Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity
2008
Body Fatness and Cancer — Viewpoint of the IARC Working Group
2016 Standout
Thyroid cancer
2016 Standout
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
2006 Standout
The role of the graft in establishing tolerance
2002
Familial thyroid cancer: a review
2011
Prevalence and prognostic significance of tall cell variant of papillary thyroid carcinoma
2006
AKT/PKB Signaling: Navigating Downstream
2007 Standout
Minimal-invasives follikuläres Schilddrüsenkarzinom
2010
Follicular Thyroid Carcinoma
2005
Treatment of patients with anaplastic thyroid cancer during the last 20 years: whether any progress has been made?
2014
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
Cell Signaling by Receptor Tyrosine Kinases
2010 Standout
The Dendritic Cell System and its Role in Immunogenicity
1991 Standout
The place of lymphatic mapping and sentinel node biopsy in oncology
2003
Hürthle cell Thyroid Carcinoma Presenting as A “Hot” Nodule
2011
Lung Cancer
2008 Standout
Cancer drug resistance: an evolving paradigm
2013 Standout
Differentiated thyroid carcinoma: defining new paradigms for postoperative management
2013
Mitogen-activated Protein Kinase Kinase-4 Promotes Cell Survival by Decreasing PTEN Expression through an NFκB-dependent Pathway
2006
Follicular lesions of the thyroid: A retrospective study of 1,348 fine needle aspiration biopsies
2010
Surgery and Radiotherapy Improves Survival in Patients With Anaplastic Thyroid Carcinoma
2008
Results of combined treatment of anaplastic thyroid carcinoma (ATC)
2011
The biology and function of fibroblasts in cancer
2016 Standout
Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies
2008
Familial nonmedullary thyroid carcinoma—clinical relevance and prognosis. A European multicenter study
2010
Thyroidectomy followed by fosbretabulin (CA4P) combination regimen appears to suggest improvement in patient survival in anaplastic thyroid cancer
2012
Anaplastic Thyroid Carcinoma: Pathogenesis and Emerging Therapies
2010
Effects of extracellular matrix viscoelasticity on cellular behaviour
2020 StandoutNature
The post ACOSOG Z0011 era: Does our new understanding of breast cancer really change clinical practice?
2012
Tyrosine kinase oncoprotein, RET/PTC3, induces the secretion of myeloid growth and chemotactic factors
2003
Is the Serum Thyroglobulin Response to Recombinant Human Thyrotropin Sufficient, by Itself, to Monitor for Residual Thyroid Carcinoma?
2002
The molecular biology of head and neck cancer
2010 Standout
Up-Regulation of ALG-2 in Hepatomas and Lung Cancer Tissue
2003
Thyroid Gland Malignancies
2015
Epidemiological patterns of leukaemia in 184 countries: a population-based study
2017
Body mass index, height and risk of lymphoid neoplasms in a large United States cohort
2012
Targeting the phosphoinositide 3-kinase pathway in cancer
2009 Standout
Global cancer statistics
2011 Standout
Influence of age and primary tumor size on the risk for residual/recurrent well‐differentiated thyroid carcinoma
2009
Improved Staging of Node-Negative Patients With Intermediate to Thick Melanomas (>1 mm) With the Use of Lymphatic Mapping and Sentinel Lymph Node Biopsy
2001
p21 in cancer: intricate networks and multiple activities
2009 Standout
Chemotherapy and the war on cancer
2005 Standout
Anaplastic Thyroid Carcinoma, Thyroid Lymphoma, and Metastasis to Thyroid
2006
ALG-2 Attenuates COPII Budding In Vitro and Stabilizes the Sec23/Sec31A Complex
2013 StandoutNobel
Interstitial Dendritic Cells
1990
Anaplastic thyroid cancer: Clinical outcomes with conformal radiotherapy
2009
Clinical outcome of anaplastic thyroid carcinoma treated with radiotherapy of once‐ and twice‐daily fractionation regimens
2006
Staging systems for follicular thyroid carcinoma: application to 171 consecutive patients treated in a tertiary referral centre
2007
Anterior chamber-associated immune deviation, ocular immune privilege, and orthotopic corneal allografts
1999
Thyroglobulin antibody (TgAb) methods – Strengths, pitfalls and clinical utility for monitoring TgAb-positive patients with differentiated thyroid cancer
2013
VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment
2004 Standout
Staging Systems for Papillary Thyroid Carcinoma
2007
Combined treatment of anaplastic thyroid carcinoma with surgery, chemotherapy, and hyperfractionated accelerated external radiotherapy
2004
Familial Follicular Cell-Derived Thyroid Carcinoma
2012
Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
2007 Standout
Validation of the QTNM staging system for cancer-specific survival in patients with differentiated thyroid cancer
2013
Emerging Biological Principles of Metastasis
2017 Standout
Diagnostic and therapeutic strategies for minimally and widely invasive follicular thyroid carcinomas
2009
Subclinical lymph node metastasis in papillary thyroid microcarcinoma: A study of 551 resections
2010
Changing incidence of AIDS-related Kaposi sarcoma and non-Hodgkin lymphoma in Ontario, Canada
2008
Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
2015 Standout
Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology
2012 Standout
Regulatory T cells in transplantation tolerance
2003 StandoutNobel
The role of tumour–stromal interactions in modifying drug response: challenges and opportunities
2013
Prognostic Importance of Histologic Vascular Invasion in Papillary Thyroid Carcinoma
2005
Effects of Insulin-like Growth Factor Binding Protein-3 and Farnesyltransferase Inhibitor SCH66336 on Akt Expression and Apoptosis in Non-Small-Cell Lung Cancer Cells
2004
Id proteins at the cross-road of development and cancer
2001
Breast Cancer Prognosis and Occult Lymph Node Metastases, Isolated Tumor Cells, and Micrometastases
2010
Degradation of the Id2 developmental regulator: targeting via N-terminal ubiquitination
2004 StandoutNobel
Emerging therapeutics for advanced thyroid malignancies: rationale and targeted approaches
2011
Approach to the Patient with Anaplastic Thyroid Carcinoma
2012
Multimodality treatment for anaplastic thyroid carcinoma – Treatment outcome in 75 patients
2009
Prognostic Importance of Vascular Invasion in Papillary Thyroid Carcinoma
2000
Induction of Stem Cell Factor/c-Kit/Slug Signal Transduction in Multidrug-resistant Malignant Mesothelioma Cells
2004
Primary brain tumours in adults
2012 Standout
Laboratory services for thyroglobulin and implications for monitoring of differentiated thyroid cancer
2009
Does radioiodine therapy have disadvantageous effects in non‐iodine accumulating differentiated thyroid carcinoma?
2002
Follicular Thyroid Carcinoma in an Iodine-Replete Endemic Goiter Region
2009
The functions and regulation of the PTEN tumour suppressor
2012 Standout
Printable organometallic perovskite enables large-area, low-dose X-ray imaging
2017 StandoutNature
Cancer and the chemokine network
2004 Standout
The PI3K Pathway in Human Disease
2017 Standout
Anaplastic thyroid carcinoma: clinical outcome of 30 consecutive patients referred to a single institution in the past 5 years
2007
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
2009 Standout
Staging Systems for Papillary Thyroid Carcinoma
2007
Clinical Utility of Thyroglobulin Antibody (TgAb) Measurements for Patients with Differentiated Thyroid Cancers (DTC)
2011
High-dose methotrexate for elderly patients with primary CNS lymphoma
2008
Intragenic Mutations in Thyroid Cancer
2008
Update on Differentiated Thyroid Cancer Staging
2014
CXC Chemokine Receptor 4 Expression and Function in Human Anaplastic Thyroid Cancer Cells
2003
Comparison of clinical characteristics at diagnosis and during follow-up in 118 patients with Hurthle cell or follicular thyroid cancer
2008
MR elastography of breast lesions: Understanding the solid/liquid duality can improve the specificity of contrast‐enhanced MR mammography
2007
PIK3CA mutation and amplification in human lung cancer
2007
Early Involvement of the Phosphatidylinositol 3-Kinase/Akt Pathway in Lung Cancer Progression
2004
Outcomes and Prognostic Factors of 251 Patients with Minimally Invasive Follicular Thyroid Carcinoma
2012
The Association Between Thyroid Carcinoma and Hashimoto's Thyroiditis: The Ultrasonographic and Histopathologic Characteristics of Malignant Nodules
2010
Sequential Changes of Serum Antithyroglobulin Antibody Levels Are a Good Predictor of Disease Activity in Thyroglobulin-Negative Patients with Papillary Thyroid Carcinoma
2013
Comparison with Published Systems of a New Staging System for Papillary and Follicular Thyroid Carcinoma
2012
American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
2012
Clinical Trials for Progressive Differentiated Thyroid Cancer: Patient Selection, Study Design, and Recent Advances
2009
The Long-Term Outcomes of the Second Generation of Familial Nonmedullary Thyroid Carcinoma Are More Aggressive than Sporadic Cases
2012
Prevalence, Clinicopathologic Features, and Somatic Genetic Mutation Profile in Familial Versus Sporadic Nonmedullary Thyroid Cancer
2010
Multivariate Analysis of the Relationship Between Male Sex, Disease-Specific Survival, and Features of Tumor Aggressiveness in Thyroid Cancer of Follicular Cell Origin
2012
Poorly Differentiated Follicular Thyroid Carcinoma: Prognostic Factors and Relevance of Histological Classification
2007
False-Negative Fine-Needle Aspiration Cytology Results Delay Treatment and Adversely Affect Outcome in Patients with Thyroid Carcinoma
2004
Prognosis and Prognostic Factors for Distant Metastases and Tumor Mortality in Follicular Thyroid Carcinoma
2011
Thyroid Lobe Ablation with Radioactive Iodine as an Alternative to Completion Thyroidectomy After Hemithyroidectomy in Patients with Follicular Thyroid Carcinoma: Long-Term Follow-Up
2012
Prognosis of Differentiated Thyroid Cancer in Relation to Serum Thyrotropin and Thyroglobulin Antibody Status at Time of Diagnosis
2013
Factors Related to the Recurrence of Thyroid Nodules after Surgery for Benign Radiation-Related Nodules
2007
Clinical Characteristics and Outcome of Familial Nonmedullary Thyroid Cancer: A Retrospective Controlled Study
2010
Enhanced Survival in Locoregionally Confined Anaplastic Thyroid Carcinoma: A Single-Institution Experience Using Aggressive Multimodal Therapy
2010
In Patients with Thyroid Cancer of Follicular Cell Origin, a Family History of Nonmedullary Thyroid Cancer in One First-Degree Relative Is Associated with More Aggressive Disease
2011
Primary lymphoma of the central nervous system: just DLBCL or not?
2008
Primary CNS Lymphoma in Immunocompetent Patients
2009
RET as a Diagnostic and Therapeutic Target in Sporadic and Hereditary Endocrine Tumors
2006
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013
2017 Standout
Structure of the STRA6 receptor for retinol uptake
2016 StandoutScienceNobel
The role of the graft in establishing tolerance
2002
Breast Cancer–Associated PIK3CA Mutations Are Oncogenic in Mammary Epithelial Cells
2005
Prognostic Value of [18F]Fluorodeoxyglucose Positron Emission Tomographic Scanning in Patients with Thyroid Cancer
2000
Over Expression of ID-1 in Prostate Cancer
2002
An Evidence‐based Approach to Familial Nonmedullary Thyroid Cancer: Screening, Clinical Management, and Follow‐up
2007
Die Rolle der externen Strahlentherapie bei der Behandlung des Schilddrüsenkarzinoms
2010
Can we interpret serum thyroglobulin results?
2012
Follicular thyroid cancer in children and adolescents: clinicopathologic features, long-term survival, and risk factors for recurrence
2013
Clonal B cells in patients with hepatitis C virus–associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset
2011 StandoutNobel
American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer
2005 Standout
Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomy
2005
Initial Management and Follow-up of Differentiated Thyroid Cancer in Children
2010
Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era
2008
Differentiated Thyroid Cancer: Management of Patients with Radioiodine Nonresponsive Disease
2012
Phase II Study of the Farnesyl Transferase Inhibitor R115777 in Patients With Advanced Non–Small-Cell Lung Cancer
2003
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis
2017 Standout
Follicular Adenoma and Carcinoma of the Thyroid Gland
2011
Current Strategies for Surgical Management and Adjuvant Treatment of Childhood Papillary Thyroid Carcinoma
2004
Exposing the Thyroid to Radiation: A Review of Its Current Extent, Risks, and Implications
2010
Guidelines for the management of thyroid cancer
2014 Standout
Management of follicular thyroid carcinoma should be individualised based on degree of capsular and vascular invasion
2010
Hereditary Non‐medullary Thyroid Cancer
2007
Level of Id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumors.
2003
B7-H1-Induced Apoptosis as a Mechanism of Immune Privilege of Corneal Allografts
2006
Minimally invasive follicular thyroid cancer (MIFTC)—a consensus report of the European Society of Endocrine Surgeons (ESES)
2013
PD-1 and Its Ligands in Tolerance and Immunity
2008 Standout
Thyroid carcinoma
2003 Standout
Works of Patrick Treseler being referenced
The Expression of HLA Antigens by Cells in the Human Cornea
1984
Follicular thyroid carcinoma: Histology and prognosis
2004
The helix-loop-helix transcription factor, Id-1, is overexpressed in medullary thyroid cancer
2000
A phase II trial of rosiglitazone in patients with thyroglobulin-positive and radioiodine-negative differentiated thyroid cancer
2006
PATHOLOGIC ANALYSIS OF THE SENTINEL LYMPH NODE
2000
Failure to Harvest Sentinel Lymph Nodes Identified by Preoperative Lymphoscintigraphy in Breast Cancer Patients
2003
A Val 677 Activating Mutation of the Thyrotropin Receptor in a Hürthle Cell Thyroid Carcinoma Associated with Thyrotoxicosis
1999
Classification and treatment of follicular thyroid neoplasms are discordant between and within medical specialties
1999
c-Kit Is Not Expressed in Malignant Mesothelioma
2003
Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series
2000
The Effect of Sentinel Node Tumor Burden on Non–Sentinel Node Status and Recurrence Rates in Breast Cancer
2005
Pathologic Examination of the Sentinel Lymph Node
2005
Id1 Gene Expression Is Up-Regulated in Hyperplastic and Neoplastic Thyroid Tissue and Regulates Growth and Differentiation in Thyroid Cancer Cells
2004
Prognostic Scoring Systems in Patients with Follicular Thyroid Cancer: A Comparison of Different Staging Systems in Predicting the Patient Outcome
2004
Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival
2001
Pathologic Correlates of Primary Central Nervous System Lymphoma Defined in an Orthotopic Xenograft Model
2009
Coexisting Chronic Lymphocytic Thyroiditis and Papillary Thyroid Cancer Revisited
2001
Accuracy of fine-needle aspiration cytology in patients with radiation-induced thyroid neoplasms
2003
Prognostic Factors in Thyroid Carcinoma
1997
THE RELATIVE IMMUNOGENICITY OF CORNEAL EPITHELIUM, STROMA, AND ENDOTHLIUM
1986
Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph)
2007
Gene expression and angiotropism in primary CNS lymphoma
2006
Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival
2001
THE EXPRESSION OF MAJOR HISTOCOMPATIBILITY COMPLEX AND LEUKOCYTE ANTIGENS BY CELLS IN THE RAT CORNEA
1986
Genomic copy number analysis of non-small cell lung cancer using array comparative genomic hybridization: implications of the phosphatidylinositol 3-kinase pathway.
2002